Self-Efficacy. The Effect of Self-Efficacy on Treatment Outcomes of Clients Enrolled in a Methadone Treatment Program in Rural Maryland
|
|
- Calvin Stevens
- 6 years ago
- Views:
Transcription
1 The Effect of Self-Efficacy on Treatment Outcomes of Clients Enrolled in a Methadone Treatment Program in Rural Maryland Bonnie A. Franckowiak, DNP, FNP, CARN-AP Self-Efficacy The belief in one s capabilities to organize and execute the courses of action required to manage prospective situations. - Albert Bandura, 1986
2 Self-Efficacy is belief in one s ability to succeed at tasks. General Self-Efficacy is belief in one s general ability to succeed at tasks. Specific Self-Efficacy refers to beliefs about one s ability to handle specific tasks. Why Study Self-Efficacy?
3 Addiction is a Medical Disease Addiction is a chronic, relapsing brain disease, which has implications not only as an individual health problem, but also as a public health problem. It impacts the drug abuser and the community on a physical, mental, psychological and social level. (Qureshi, Al-Ghamdy, & Al-Habeeb, 2000) Background: Opiate Addiction 24.6 million Americans used illicit drugs in 2013 (9.4%) National cost is approx. $700 billion annually >8,000 new users daily (SAMHSA, 2014)
4 Background (cont.) Public health problem with global implications Contributes to global mortality and morbidity (NIDA, 2011) Global Burden of Disease DALY = Disability Adjusted Life Years The number of years of potential life lost due to premature mortality and the years of productive life lost due to disability.
5 Global Burden of Substance Abuse Drug dependence responsible for 20 million DALYs in 2010 Opioid dependence was the largest contributor, with 9.2 million Highest burden in higher income countries Illustrates increased need for treatment (Degenhardt, et al. 2013) Treatment: A Research-based Guide (NIDA, 1999) No single treatment is appropriate for all individuals. Treatment must attend to multiple need of the individual, not just drug use. Remaining in treatment for an adequate period of time is critical for treatment effectiveness.
6 Medication assisted treatment (MAT) using Methadone Gold standard of opiate treatment Strict state and federal regulations Individualized according to need MAT (cont.) Pharmacology, counseling, and behavioral therapy Comprehensive approach; Individualized care Goal: return to a state of health and well-being, and function well in family and community Low cost, safe, and effective; Accepted world-wide
7 LITERATURE REVIEW Literature Review Retention in treatment Psychosocial support Behavior change Self-Efficacy Health Belief Model
8 Retention in Treatment Client satisfaction leads to improved outcomes. Kelly, O Grady, Mitchell, Brown & Schwartz; 2011 Chronic illness is best treated collaboratively by client and provider. VonKorff, Gruman, Curry & Wagner; 1997 Adequate methadone dosing, psychiatric care, and behavioral counseling are key to successful treatment. Ciraulo, Piechniczek-Buczek & Iscan; 2003 Individualized treatment plans are associated with better retention and outcomes. Hser, Evans, Huang & Anglin; 2004 Psychosocial Support Satisfaction and rapport with staff leads to a decrease in illicit drug use, better compliance with treatment, and improved outcomes. Joe, Simpson, Dansereau Rowan-Szal; 2001 Clients who felt that needs were met during treatment stayed abstinent longer at 1 year follow up. Zhang, Gerstein & Freidmann; 2008 Outcomes improve when psychosocial support is added to medication treatment, compared to medication alone. Amato, Minozzi, Davoli, Vecchi, Ferri & Mayet; 2009
9 Behavior Change Motivation is an important factor in behavior change Kelly, Zyzanski & Alemagno; Self-efficacy affects the decision whether or not to initiate behavior change. Stewart, Wolfe, Maeder & Hartz; 1996 Maintenance of new behaviors is related to self-efficacy. Scherbaum; 2008 Self- Efficacy Positive health behavior is related to high self-efficacy. Schwarzer & Fuchs; 1995 Efforts to improve self-efficacy lead to improved treatment outcome and retention. Bourbeau; 2008 : Senbanjo, Wolff, Marshall & Strang; 2009 Alcoholics with high self-efficacy resisted temptation to drink for longer time periods. Vielva & Iraurgi; 2001: Allsop,Saunders&Phillips;2000
10 Self-efficacy is a fluid, dynamic concept. Why is Self-Efficacy important? Past Performance Verbal Persuasion Vicarious Experience Psychological / Emotional States Self-Efficacy Feelings Thoughts Motivation Actions
11 Health Belief Model (HBM) One of the most widely accepted and frequently used models for study and implementation of behavior change. Harrison, Mullen & Green; 1992 Proven useful in improving patient compliance in many studies related to various chronic illnesses. HEALTH B Orel et al.; 2010: Ghaddar et al.; 2009: Koch; 2002 HBM (cont.) Four conditions for behavior change: The belief that one is at risk of developing a specific condition. The belief that the risk is serious and the consequences are undesirable. The belief that the risk will be reduced by behavior change. The belief that barriers to behavior change can be overcome and managed. (Janz & Becker, 1984)
12 Health Belief Model Demographic variables (age, sex, race, ethnicity, etc.) Sociopsychological variables Perceived benefits of preventive action minus Perceived barriers to preventive action Perceived Susceptability to Disease X Perceived Seriousness (Severity) of Disease X Perceived Threat of Disease X Likelihood of Taking Recommended Preventive Health Action Cues to Action Mass media campaigns Advice from others Reminder postcard from physician/dentist Illness of family member or friend Newspaper or magazine article Janz & Becker, 1984 METHODOLOGY
13 Purpose: To determine if measurement of self-efficacy can be a useful tool in treatment of the opiate addicted client. Research Questions 1. Are MAT and self-efficacy related? 2. Are self-efficacy and treatment outcomes related?
14 The General Self-efficacy Scale (GSE) 1. I can always manage to solve difficult problems if I try hard enough. 2. If someone opposes me, I can find the means to get what I want. 3. It is easy for me to stick to my aims and accomplish my goals. 4. I am confident that I could deal efficiently with unexpected events. 5. Thanks to my resourcefulness, I can handle unforeseen circumstances. 6. I can solve most problems if I invest the necessary effort. 7. I can remain calm when facing difficulties because I can rely on my coping abilities. 8. When I am confronted with a problem, I can usually find several solutions. 9. If I am in trouble, I can usually think of a solution. 10. Responses: I can usually 1= Not handle at all true. whatever 2 = Hardly comes true. my 3 way. = Moderately true. 4 = Exactly true. English version by Schwarzer & Jerusalem, 1995 Specific Self-efficacy Additional questions relating specifically to opiate dependence added by researcher. 11. If I ran into old friends who offered me pills or heroin, I could resist. 12. I can stay away from people I used to use with, and I feel strong. 13. If I was in a situation where people were using drugs, I would have the strength to leave. 14. I feel that I am able to cope with stress in ways other than using drugs. Responses: 1= Not at all true. 2 = Hardly true. 3 = Moderately true. 4 = Exactly true. Franckowiak, 2011
15 Variable s change in self-efficacy scores number of opiate-free urines monthly group attendance monthly individual counseling sessions STUDY DESIGN
16 The Study Admission process including GSE Initiate Standard MAT After 6 months +/- 4 days Obtain informed consent Repeat GSE Retrospective record review of outcome measures Study Site: Serenity Health, LLC Elkton, MD Site Demographics: 96% Caucasian, 3% African American 54% female, 70% unemployed, 4% disabled 80% Medicaid, 20% self-pay Average age 34 years
17 Analysis of Data QUESTION #1: Are MAT and self-efficacy related? Comparison of (Post- minus Pre-treatment) scores using Paired t-test QUESTION #2: Are self-efficacy and treatment outcomes related? Correlation of group and individual sessions, and number of opiate-negative urine screens using Pearson Correlation RESULTS
18 MEAN PRE-TREATMENT GSE SCORES BY GENDER Pre GSE (General) Pre GSE (Specific) Pre GSE (Total) Gender Mean N Std. Dev. Females Males Combined Females Males Combined Females Males Combined MEAN POST-TREATMENT GSE SCORES BY GENDER Post GSE (General) Post GSE (Specific) Post GSE (Total) Females Males Combined Females Males Combined Females Males Combined
19 COMPARISON OF PRE- & POST- TREATMENT GSE SCORES Post-Pre GSE score (general) Post-Pre GSE score (specific) Post-Pre GSE score (total) t p value Range Average Increase Research Question #1 Is MAT related to self-efficacy? In this study, MAT does appear to be related to self-efficacy.
20 CORRELATION OF GSE SCORES AND NUMBER OF OPIATE NEGATIVE URINE SCREENS Negative Urine Pre GSE (General) Pre GSE (Specific) Pre GSE (Total) Pearson Correlation Sig. (2-tailed) N CORRELATION OF GSE SCORES AND INDIVIDUAL AND GROUP SESSIONS Individual Sessions Group Sessions Pearson Correlation Sig. (2- tailed) Pearson Correlation Sig. (2- tailed) Pre GSE (General) Pre GSE Pre GSE (Specific) (Total) N
21 Research Question #2 Are self-efficacy and treatment outcomes related? No correlation was found between self-efficacy scores and any of the treatment outcomes measured. Descriptive Data High GSE scores yielded more opiate negative urine screens. Subjects with high GSE scores preferred groups. Subjects with low GSE scores preferred individual sessions. Five subjects had unchanged or lowered GSE scores. 28 of 50 subjects identified completed the study.
22 Transferred to other treatment facility 3 Moved out of area Medical issues / Hospitalization Incarceration Administrative discharge Referred to pain management Left AMA Unknown Participants who did not complete the study (n = 22) DISCUSSION & RECOMMENDATIONS
23 Strengths of the Study Homogeneity of sample All subjects received same MAT protocol Inter-rater reliability Met 6 month minimum for MAT Limitations of the Study Small sample size High attrition rate Did not control for additional group attendance Did not control for type of group attended
24 Recommendations for Research Replicate with larger sample size and longer duration. Add measure of stress level. Assess motivation for treatment. Control for other variables (onset of drug use, treatment history, and concurrent substance use). Add control group who receives an intervention to increase self-efficacy. Recommendations for Practice Repeat GSE at intervals throughout treatment, and incorporate into Relapse Prevention programs. Continue use of GSE testing as an aid in treatment planning and counselor assignment. Use GSE testing to strengthen patient assessment, and view of whole person.
25 Follow Up at One Year Of the 28 subjects who completed the original study, 22 remained in treatment.
26 Final thought... Self-belief does not necessarily ensure success, but selfdisbelief assuredly spawns failure. - Albert Bandura From Self-Efficacy: The exercise of Control, 1997
27 Questions & Discussion Thank you.
Assessing Readiness To Change
Assessing Readiness To Change Transtheoretical Model The Transtheoretical Model describes the stages of behavior prior to change. It focuses on the individual s decision making. This model involves the
More informationThe Value of Engagement in Substance Use Disorder (SUD) Treatment
The Value of Engagement in Substance Use Disorder (SUD) Treatment A Report from Allegheny HealthChoices, Inc. June 2016 Introduction When considering substance use disorder (SUD) treatment, the length
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationImproving Outcomes in Methadone Treatment
Improving Outcomes in Methadone Treatment Cognitive/Behavioral Treatment Contingency Management Michael J. McCann, MA Matrix Institute on Addictions COMP Symposium September 11, 2007 Overview of Presentation
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationMindfulness and self- regulation skills - Introduction
Mindfulness and self- regulation skills - Introduction Because FASD is a neurodevelopmental disability that can affect cognitive skills and executive functioning (i.e. inhibition, problem solving, attention,
More informationTreatment Issues: The Opiate Crisis Among Us
Treatment Issues: The Opiate Crisis Among Us Presenter: Jessica Cirillo, BS, MA, ACRPS Clinical Supervisor & Relapse Prevention Specialist with Mirmont Treatment Center Facts About Addiction Addiction
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationIntNSA Webinar Series
BUPRENORPHINE CLINIC: A MULTIDISCIPLINARY MODEL FOR OPIOID MAINTENANCE THERAPY Stephen Strobbe, PhD, RN, NP, PMHCNS-BC, CARN-AP Monday, June 4, 2012 IntNSA Webinar Series Funding for this webinar was made
More informationTrigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!
More information3/6/2017. Grassroots Strategies for Improving Adherence. Learning Objectives
Grassroots Strategies for Improving Adherence Amy Knight, PhD Director of Rehabilitation Psychology Department of Physical Medicine & Rehabilitation University of Alabama Birmingham Nothing to Disclose
More informationProviding Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics
More informationThe available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication
More informationImproving the Quality of Addiction Treatment
Improving the Quality of Addiction Treatment Expanding Access to Medication-Assisted Treatment in Residential Addiction Treatment Programs Webinar sponsored by RTI International January 18, 2018 RTI International
More informationMethadone Maintenance 101
Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms
More informationTHE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT MARK DUNCAN MD UNIVERSITY OF WASHINGTON SPEAKER DISCLOSURES Any conflicts
More informationEvidence-Based Practice: Psychosocial Interventions
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio Talk Outline What is an evidence-based practice?
More informationFY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
More informationIMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT
2014 CTN Web Seminar Series IMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT Presented by: Robert Lindblad, MD & Gaurav Sharma, PhD NIDA Clinical Coordinating & Data and Statistics Centers The EMMES
More informationChild Welfare and MOMS: Building Partnerships to Improve Care
Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) For Apple Health clients served Fee-for-Service and through contracted Medicaid Managed Care Organizations Updated January
More informationState Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment
State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment DEPARTMENT OF HUMAN SERVICES (DHS) DIVISION OF MENTAL HEALTH & ADDICTION SERVICES (DMHAS) STORI INFORMATIONAL WEBINAR
More informationNoel Schenk MD. Davis Behavioral Health
Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by
More informationTreatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS
Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS Robert Walker, M.S.W., L.C.S.W. University of Kentucky Center on Drug and Alcohol Research Kentucky Substance Abuse
More informationLimiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?
University of Massachusetts Medical School escholarship@umms Commonwealth Medicine Publications Commonwealth Medicine 6-25-2014 Limiting the Duration of Medication Assisted Treatment for Opioid Addiction:
More informationManagement Options for Opioid Dependence:
Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice
More informationUse of Reminder Messages to Improve Utilization of an Automated Telephone-Based Treatment for Methadone Patients
Use of Reminder Messages to Improve Utilization of an Automated Telephone-Based Treatment for Methadone Patients Destiny M.B. Printz, B.A. Daniel P. Lloyd, M.A. Frank D. Buono, Ph.D. Brent A. Moore, Ph.D.
More informationOpioid Treatment Program Reimbursement Re-bundling Proposal
Opioid Treatment Program Reimbursement Re-bundling Proposal Maryland Department of Health and Mental Hygiene April 22, 2016 The Department reviewed close to 50 letters and emails submitted by stakeholders
More informationSTARTING SUBOXONE IN PRIMARY CARE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences STARTING SUBOXONE IN PRIMARY CARE MARK DUNCAN MD UNIVERSITY OF WASHINGTON OBJECTIVES 1. Review evidence of how to
More informationAllegany Rehabilitation Associates Personalized Recovery Oriented Services. PROS Service: Intensive Rehabilitation-Integrated Dual Disorder Treatment
Total Number of Sessions: Approximately 15 weeks Duration of each session: 45 minutes PROS Service: Intensive Rehabilitation-Integrated Dual Disorder Treatment Maximum number of participants: 8 Staff Qualifications:
More informationTrends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville
Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted
More informationModels for Involvement in Physical Activity
Models for Involvement in Physical Activity Why do people embrace or do not embrace a physical active lifestyle? 1 Typical Undergrad Complaints What s the point? Aren t these all the same? What does this
More informationProject Connections Buprenorphine Program
Project Connections Buprenorphine Program Program & Client Summary 2010-2017 Behavioral Health Leadership Institute November 2017 November 2017 1 Table of Contents I. Overview of the Project Connections
More informationSubstance Use Trends in the Military, Veteran and Family Population
Substance Use Trends in the Military, Veteran and Family Population Prepared by: Shana Malone Arizona Criminal Justice Commission Statistical Analysis Center National Illicit Drug Use 1 in 10 individuals
More informationSelf-efficacy Evaluation Survey on Chinese Employees: Case of Electronics Limited Company X1 (Shenzhen) & Investments Company Limited X2 (Beijing)
Self-efficacy Evaluation Survey on Chinese Employees: Case of Electronics Limited Company X (Shenzhen) & Investments Company Limited X2 (Beijing) Rodrigue Againglo*, Jun Shan Gao, Karani N. Nyachiro University
More informationOPIOIDS IN AMERICA. A complex crisis. A comprehensive response.
OPIOIDS IN AMERICA A complex crisis. A comprehensive response. Prescription opioids play a critical role in helping millions of people effectively manage chronic pain. But for some, opioid use has become
More informationHARM REDUCTION & TREATMENT. Devin Reaves MSW
HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that
More informationBuprenorphine as a Treatment Option for Opioid Use Disorder
Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital
More informationWhat is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives
Clinical Evaluation: Treatment Planning Goals and Objectives 1) Define Treatment Planning 2) Understanding of Correlation Between Assessment and Treatment Planning 3) Overview of Treatment Planning Process
More informationPOLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE MARK DUNCAN, MD November 8, 2018 SPEAKER
More informationKaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System
Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System 12-Month Customer Report, January to December, 2007 We exist to help
More informationTHE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Special Report: Opioid Admissions in Iowa August 2016
Special Report: State of Iowa Opioid Treatment Admissions 21-215 THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Special Report: Opioid Admissions in Iowa 21-215 August 216 With Funds Provided
More informationOverview of Treatment Engagement Findings from DATOS
Drug Abuse Outcome Studies (Funded by NIDA) Overview of Engagement Findings from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA),
More informationFrom Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5)
From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5) Region 5 Fatherhood Initiative October 24, 2017 Today s Presentation Public
More information15 INSTRUCTOR GUIDELINES
STAGE: Former Tobacco User You are a pharmacist at an anticoagulation clinic and are counseling one of your patients, Mrs. Friesen, who is a 60-year-old woman with a history of recurrent right leg deep
More informationAddiction Environmental Scan: Mapping Addictions in the Central East LHIN (CELHIN) - Defining the Gaps and Opportunities Project
: Mapping Addictions in the Central East LHIN (CELHIN) - Defining the Gaps and Opportunities Project For further information please go to: http://www.health.gov.on.ca/english/public/program/mentalhealth/minister_advisgroup/m
More informationHow serious is the opiate problem in Fairfield County?
How serious is the opiate problem in Fairfield County? The Use of Opiates in Fairfield County has increased from levels in the 1990's that were barely detectable to epidemic proportions in 2010. How serious
More informationSubstance Use Disorders: A System Overview
Substance Use Disorders: A System Overview For Senate Human Services and Early Childhood Karen Wheeler, M.A. Behavioral Health Programs Administrator Addictions and Mental Health Division Substance use
More informationIn 2008, an estimated 282,000 persons
National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Similarities and Differences in Opioid Treatment Programs that Provide Methadone Maintenance or Buprenorphine Maintenance
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationRECOMMENDATIONS FOR HEALTH CARE PROVIDERS
Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the
More informationThe Social Worker s Role in Medication Assisted Treatment
The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment
More informationBrief History of Methadone Maintenance Treatment
METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what
More informationReport to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report
Report to The Vermont Legislature Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report In Accordance with Act 179 () Sec. E.306.2 (a)(2) Submitted to: Submitted
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationOutlook and Outcomes Fiscal Year 2011
Baltimore Substance Abuse Systems, Inc. Outlook and Outcomes Fiscal Year 2011 Baltimore City Greg Warren, President Compiled July 2012 BSAS Outlook and Outcomes is the first edition of a planned annual
More informationBehavioral EQ MULTI-RATER PROFILE. Prepared for: By: Session: 22 Jul Madeline Bertrand. Sample Organization
Behavioral EQ MULTI-RATER PROFILE Prepared for: Madeline Bertrand By: Sample Organization Session: Improving Interpersonal Effectiveness 22 Jul 2014 Behavioral EQ, Putting Emotional Intelligence to Work,
More informationMedication-Assisted Treatment (MAT) Overview
Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for
More informationExploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications
MWSUG 2017 - Paper DG02 Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications ABSTRACT Deanna Naomi Schreiber-Gregory, Henry M Jackson
More informationTHE HEALTH BELIEF MODEL. Health Behavior CHAPTER 6
THE HEALTH BELIEF MODEL 1 DESCRIPTION This chapter will discuss The Health Belief Model, Protection Motivation Theory and how to use the model in the behavior case analysis 2 OBJECTIVES General The student
More informationROSC & MAT II: Opioid Treatment Services
ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify
More informationChild Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network
Child Welfare and Substance Abuse Erica Tarasovitch, MSW Central Florida Behavioral Health Network Parental Substance Use Marijuana was the most commonly used illicit drug in 2006, accounting for 72.8
More informationTWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION
Appendix G PHASE OF MANAGEMENT NOTIFICATION ASSESSMENT TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION ACTIONS All patients will be advised on admission that :
More informationSelf-efficacy, Positive Thinking, Gender Difference as Predictors of Academic Achievement in Al Jouf University Students-Saudi Arabia
International Journal of Psychology and Behavioral Sciences 207, 7(6): 43-5 DOI: 0.5923/j.ijpbs.2070706.0 Self-efficacy, Positive Thinking, Gender Difference as Predictors of Academic Achievement in Al
More informationCore Competencies - Smoking Cessation Fundamentals
Core Competencies - Smoking Cessation Fundamentals This training standard was developed for the National Training Service (NTS) Alliance in consultation with subject matter experts. The purpose of this
More informationCounseling and Testing for HIV. Protocol Booklet
Counseling and Testing for HIV Protocol Booklet JHPIEGO, an affiliate of Johns Hopkins University, builds global and local partnerships to enhance the quality of health care services for women and families
More informationFAMILY FUNCTIONAL THERAPY (FFT) - Youth. Program Description
Clinical FAMILY FUNCTIONAL THERAPY (FFT) - Youth Program Description Family Functional Therapy (FFT) is a family-focused, community-based treatment for youth who are either at risk for, or who manifest,
More informationYour Child s Treatment Roadmap
Your Child s Treatment Roadmap The road to recovery isn t the same for everyone. There are many options to consider for your son, daughter, or loved one. Our guide outlines key steps to help you make the
More informationDavid O Malley, Ph.D., LISW Case Western Reserve University Cleveland, Ohio
An Examination of Factors Influencing College Students Self-Reported Likelihood of Calling for Assistance for A Fellow Student Who Has Engaged In High-Risk Alcohol Consumption David O Malley, Ph.D., LISW
More informationOpioid Treatment in North Carolina SEPTEMBER 13, 2016
Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained
More informationAmerican Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute
American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients Centerstone Research Institute 2018 1 AAC Outcomes Study: Long-Term Outcomes Executive Summary
More informationState of Iowa Outcomes Monitoring System
State of Iowa Outcomes Monitoring System THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year 17 Annual Outcome Evaluation Trend Report November 2015 With Funds Provided By: Iowa Department
More informationOrganization: NAMI Minnesota Request ID: Program Title: Reducing Smoking Among People with Mental Illnesses
Organization: NAMI Minnesota Request ID: 16872475 Program Title: Reducing Smoking Among People with Mental Illnesses 1. Overall Goal & Objectives The overall goal of this project is to reduce the rate
More informationDATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION. Biweekly Call December 14, 2016
DATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION Biweekly Call December 14, 2016 Data-Driven Justice Initiative Implementing Medication Assisted Treatment Programs for Justice Involved Populations
More informationMotivational Enhancement Therapy & Stages of Change
Motivational Enhancement Therapy & Stages of Change Learning Objectives Participants will be able to: 1) Identify the stages of change and how they can be implemented 2) Describe the principles of MET
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationThe Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016
The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of
More informationJohann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works
From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a
More informationDESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE SECTION TWO
SECTION TWO DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE 7 2.1 DEMOGRAPHIC CHARACTERISTICS Table 2.1 presents demographic descriptive data at intake for those who were included in the follow-up study. Data
More informationEXPERT PANEL AND FIELD PARTICIPANTS BELIEVE
EXPERT PANEL AND FIELD PARTICIPANTS BELIEVE 1. The overall total number of clients/cases/patients in the system has remained stable over the years; however, the proportional number of clients abusing opiates
More informationTREATING OPIOID ADDICTION IN HOMELESS POPULATIONS
TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health
More informationGeorgia Aging and Disability Resource Connection (ADRC) Evaluation Report
Georgia Aging and Disability Resource (ADRC) Evaluation Report Evaluation Report from Boston University March Prepared by: Bronwyn Keefe, MSW, MPH, PHD Associate Director, CADER Kathy Kuhn, MSW Director
More informationState of Iowa Outcomes Monitoring System
State of Iowa Outcomes Monitoring System THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year 16 Annual Outcome Evaluation Trend Report November 2014 With Funds Provided By: Iowa Department
More informationCHARACTERISTICS OF ADMISSIONS TO RESIDENTIAL DRUG TREATMENT AGENCIES IN NEW SOUTH WALES, : ALCOHOL PROBLEMS
CHARACTERISTICS OF ADMISSIONS TO RESIDENTIAL DRUG TREATMENT AGENCIES IN NEW SOUTH WALES, 1988-1992: ALCOHOL PROBLEMS Shane Darke 1, Margaret Kelahar 1, Wayne Hall 1 & Bruce Flaherty 2 1 National Drug and
More information7/7/2016 Journal of the American Medical Association,
1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of
More informationMEDICATION ASSISTED TREATMENT PRESCRIPTION DRUG AND OPIOID ADDICTION THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION
MEDICATION ASSISTED TREATMENT PRESCRIPTION DRUG AND OPIOID ADDICTION THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year One Annual Evaluation Report September 2016 With Funds Provided
More informationFamily & Children s Services MENTAL HEALTH SERVICES FOR ADULTS
Family & Children s Services MENTAL HEALTH SERVICES FOR ADULTS You don t have to suffer from mental illness. We re here to help you with problems that seem overwhelming and too difficult to handle alone.
More information*IN10 BIOPSYCHOSOCIAL ASSESSMENT*
BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding
More informationTITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness
TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness DATE: 08 October 2009 CONTEXT AND POLICY ISSUES: Poly-drug abuse is
More informationEvolutions Recovery House
Evolutions Recovery House General Information Contact Information nprofit Evolutions Recovery House Address 1261 1st Avenue rth Nashville, TN 37210 Phone (615) 593-4387 Fax 615 242-8690 Web Site Web Site
More informationBehavioral Health Hospital and Emergency Department Health Services Utilization
Behavioral Health Hospital and Emergency Department Health Services Utilization Rhode Island Fee-For-Service Medicaid Recipients Calendar Year 2000 Prepared for: Prepared by: Medicaid Research and Evaluation
More informationArwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry
The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic
More informationWhat Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016
What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)
More informationTRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS
Fact Sheet N 127 August 1996 TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Psychoactive substance use is an increasing public health concern. Problems associated with this use cover a broad spectrum
More informationSubstance Abuse Group Therapy
Substance Abuse Group Therapy Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Chapter 1 This natural propensity in humans makes group therapy a powerful
More informationAndreas Bund University of Darmstadt. Self-Confidence and Sports Performance
University of Darmstadt Self-Confidence and Sports Performance Self-Confidence and Sports Performance 2. Theoretical and Motor Performance (Moritz et al., 2000) and Motor Learning (Bund, 2001) Statements
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 2 Motivating clients for treatment and addressing resistance Basic counselling skills for drug dependence treatment Special considerations when
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More information